Cornelia Dröge

发表

Phase 2 trial of single-agent everolimus in chemotherapy-naive patients with castration-resistant prostate cancer (SAKK 08/08).

Ruedi Aebersold, Christian Rothermundt, Peter J Wild, 2013, European urology.